Oneness Biotech Co., Ltd. (TPEX:4743)
46.95
+1.35 (2.96%)
Sep 8, 2026, 1:30 PM CST
Oneness Biotech Revenue
Oneness Biotech had revenue of 39.91M TWD in the quarter ending June 30, 2026, with 49.75% growth. This brings the company's revenue in the last twelve months to 153.78M, up 36.61% year-over-year. In the year 2025, Oneness Biotech had annual revenue of 129.12M with 9.49% growth.
Revenue (ttm)
153.78M
Revenue Growth
+36.61%
P/S Ratio
142.18
Revenue / Employee
3.58M
Employees
43
Market Cap
21.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 129.12M | 11.20M | 9.49% |
| Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
| Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
| Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
| Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sunmax Biotechnology | 2.19B |
| EirGenix | 1.21B |
| Ever Supreme Bio Technology | 1.08B |
| TCM Biotech International | 701.63M |
| TaiMed Biologics | 619.49M |
| Medigen Vaccine Biologics | 573.85M |
| ACRO Biomedical | 52.76M |
| Gongwin Biopharm Holdings | 42.22M |